Optomed PlcStock Exchange Release4 August 2022 at 9.05, Helsinki
Optomed's financial reporting in 2023
Optomed Plc will release its Financial Statement Bulletin, Half-Year Financial
Report and Interim Reports in 2023 as follows:
· Financial Statement Bulletin for 1 January - 31 December 2022, 17 February
2023
· Interim Report for 1 January - 31 March 2023, 5 May 2023
· Half-Year Financial Report for 1 January - 30 June 2023, 4 August 2023
· Interim Report for 1 January - 30 September 2023, 3 November 2023
Annual Report 2022, which includes the company's financial statements, the
report of the Board of Directors, the corporate governance statement and the
remuneration report, will be published during the week starting on 27 February
2023 at the latest.
Optomed's Annual General Meeting is planned to be held on 10 May 2023 in the
Helsinki region, Finland. The Board of Directors will convene the meeting
separately at a later date.
A shareholder who requests a certain issue belonging to the General Meeting to
be included on the agenda of the meeting, is asked to notify the Board of
Directors in writing by post Optomed Plc, Yrttipellontie 1, FI-90230 Oulu,
Finland no later than 14 March 2023.
Optomed Plc
Further enquiries
Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers
of handheld fundus cameras. Optomed combines handheld cameras with software and
artificial intelligence with the aim to transform the diagnostic process of
blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its
business Optomed focuses on eye-screening devices and software solutions related
R&D in Finland and sales through different channels in over 60 countries. The
company has an extensive portfolio of 55 international patents protecting the
technology.
www.optomed.com